Head-to-head dispatch
NewSelf vs OurView Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
NewSelf offers compounded semaglutide+ (with B12/Glycine, from $99.97/mo) and compounded tirzepatide+ (with B6/Glycine, from $144.49/mo).
Marked down on: Not available in Mississippi and Louisiana
FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.
Desk Score
OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications.
Marked down on: A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
NewSelf takes this head-to-head with the higher Desk Score, 79/100 (C+) against 61/100 (C) for OurView Health. OurView Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
NewSelf
79/100
C+
OurView Health
61/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | NewSelf | OurView Health |
|---|---|---|
| Semaglutide | $100/mo (compounded) | $75/mo (starting dose, compounded) |
| Tirzepatide | $144/mo (compounded) | $135/mo (starting dose, compounded) |
| Coverage | 49 states | Coverage not published |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want lowest-cost compounded GLP-1 with pharmacy quality transparency. | Readers who want budget shoppers wanting low-cost compounded GLP-1 via a membership savings model. |
| Desk Score | 79/100C+ | 61/100C |
The verdict
Desk pick — NewSelfNewSelf takes this head-to-head with the higher Desk Score, 79/100 (C+) against 61/100 (C) for OurView Health. OurView Health still holds its ground where its strengths line up with yours.
Choose NewSelf if…
Readers who want lowest-cost compounded GLP-1 with pharmacy quality transparency.
$100/mo (compounded) sema · $144/mo (compounded) tirz · 49 states
FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.
Choose OurView Health if…
Readers who want budget shoppers wanting low-cost compounded GLP-1 via a membership savings model.
$75/mo (starting dose, compounded) sema · $135/mo (starting dose, compounded) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: NewSelf · OurView Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- NewSelf vs CoreAge Rx
- OurView Health vs Vaylen
- NewSelf vs Strut Health
- OurView Health vs Ondra Health
- NewSelf vs Invigor Medical
- OurView Health vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.